Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Rapid Communications in Mass Spectrometry

• Publication date

  2007-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/RCM.2987PMID 17410605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of urine and oral fluid as matrices for screening of thirty-three benzodiazepines and benzodiazepine-like substances using immunoassay and LC-MS(-MS).

  2006cited by this paper
• Advances in analytical toxicology: the current role of liquid chromatography–mass spectrometry in drug quantification in blood and oral fluid

  2005cited by this paper
• Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS/MS.

  2005cited by this paper
• Liquid chromatography-electrospray ionisation mass spectrometry for the determination of nine selected benzodiazepines in human plasma and oral fluid.

  2005cited by this paper
• Determination of midazolam and its major metabolite 1'-hydroxymidazolam by high-performance liquid chromatography-electrospray mass spectrometry in plasma from children.

  2005cited by this paper
• Review: Pharmacokinetics of illicit drugs in oral fluid.

  2005cited by this paper
• Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry.

  2005cited by this paper
• Review: The physiology of saliva and transfer of drugs into saliva.

  2005cited by this paper
• A highly sensitive LC-MS-MS assay for analysis of midazolam and its major metabolite in human plasma: applications to drug metabolism.

  2005cited by this paper
• Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activity.

  2004cited by this paper
• A sensitive, rapid and specific determination of midazolam in human plasma and saliva by liquid chromatography/electrospray mass spectrometry.

  2004cited by this paper
• Intravenous and oral alfentanil as in vivo probes for hepatic and first‐pass cytochrome P450 3A activity: Noninvasive assessment by use of pupillary miosis

  2004cited by this paper
• Oral administration of a low dose of midazolam (75 μg) as an in vivo probe for CYP3A activity

  2004cited by this paper
• Determination of picogram levels of midazolam, and 1- and 4-hydroxymidazolam in human plasma by gas chromatography-negative chemical ionization-mass spectrometry.

  2004cited by this paper
• Oral fluid as a diagnostic tool

  2004cited by this paper
• Rapid determination of five probe drugs and their metabolites in human plasma and urine by liquid chromatography/tandem mass spectrometry: application to cytochrome P450 phenotyping studies.

  2004cited by this paper
• Quantitative analysis of 33 benzodiazepines, metabolites and benzodiazepine-like substances in whole blood by liquid chromatography-(tandem) mass spectrometry.

  2004cited by this paper
• Ion suppression in mass spectrometry.

  2003cited by this paper
• Performance and reliability of splitless microliter gradient pumps in a metabolic stability study using cytochrome P450/3A4 and capillary liquid chromatography-mass spectrometry.

  2003cited by this paper
• Determination of midazolam and 1'-hydroxymidazolam by liquid chromatography-mass spectrometry in plasma of patients undergoing methadone maintenance treatment.

  2003cited by this paper
• Simultaneous determination of levomepromazine, midazolam and their major metabolites in human plasma by reversed-phase liquid chromatography.

  2003cited by this paper
• Use of Alternative Specimens: Drugs of Abuse in Saliva and Doping Agents in Hair

  2002cited by this paper
• Ion suppression effects in liquid chromatography-electrospray-ionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries.

  2002cited by this paper
• Interindividual variability in inhibition and induction of cytochrome P450 enzymes.

  2001cited by this paper
• Determination of midazolam in human plasma by solid-phase microextraction and gas chromatography/mass spectrometry.

  2001cited by this paper
• Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes.

  2000cited by this paper
• Sensitive and specific determination of midazolam and 1-hydroxymidazolam in human serum by liquid chromatography-electrospray mass spectrometry.

  1999cited by this paper
• Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-Glycoprotein

  1999cited by this paper
• The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds.

  1999cited by this paper
• Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: Effect of ketoconazole

  1999cited by this paper
• Analysis of midazolam and metabolites in plasma by high-performance liquid chromatography: probe of CYP3A.

  1998cited by this paper
• Methods for the measurement of benzodiazepines in biological samples.

  1998cited by this paper
• Sensitive assay for midazolam and its metabolite 1'-hydroxymidazolam in human plasma by capillary high-performance liquid chromatography.

  1998cited by this paper
• The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin

  1998cited by this paper
• Testing for drugs of abuse in saliva and sweat.

  1998cited by this paper
• Midazolam: a review of therapeutic uses and toxicity.

  1997cited by this paper
• Simultaneous determination of midazolam and its metabolites 1-hydroxymidazolam and 4-hydroxymidazolam in human serum using gas chromatography-mass spectrometry.

  1997cited by this paper
• Rifampin drastically reduces plasma concentrations and effects of oral midazolam

  1996cited by this paper
• Cytochrome P4503A (CYP3A) metabolism: Prediction ofIn Vivo activity in humans

  1996cited by this paper
• First‐pass metabolism of midazolam by the human intestine

  1996cited by this paper
• Oral first‐pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A‐mediated metabolism

  1996cited by this paper
• Application issues in bioanalytical method validation, sample analysis and data reporting.

  1995cited by this paper
• Determination of midazolam and its unconjugated 1-hydroxy metabolite in human plasma by high-performance liquid chromatography.

  1995cited by this paper
• Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.

  1994cited by this paper
• Noninvasive tests of CYP3A enzymes.

  1994cited by this paper
• Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.

  1994cited by this paper
• Determination of midazolam and two of its metabolites in human plasma by high-performance liquid chromatography.

  1994cited by this paper
• Determination of Midazolam and Its α‐Hydroxy Metabolite in Human Plasma and Urine by High‐Performance Liquid Chromatography

  1993cited by this paper
• Simultaneous determination of midazolam and its three hydroxy metabolites in human plasma by electron-capture gas chromatography without derivatization.

  1989cited by this paper
• Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

  1989cited by this paper
• Excretion and metabolism of 14C-midazolam in humans following oral dosing.

  1981cited by this paper
• Use of saliva in therapeutic drug monitoring.

  1977cited by this paper

• The clinical applications of drugs and their metabolites analysis in biological fluids and commonly used analytical techniques for bioanalysis: review

  2024cites this paper
• Salivary Biomarkers of Anti-Epileptic Drugs: A Narrative Review

  2023cites this paper
• Assessing Pleiotropic Effects of a Mixed-Mode Perpetrator Drug, Rifampicin, by Multiple Endogenous Biomarkers in Dogs

  2023cites this paper
• Sedation level with midazolam: A pediatric surgery approach

  2022cites this paper
• Oral Fluid Drug Testing: Analytical Approaches, Issues and Interpretation of Results.

  2019cites this paper
• Midazolam Efficacy Against Acute Hydrogen Sulfide-Induced Mortality and Neurotoxicity

  2018cites this paper
• Development and validation of a sensitive assay for analysis of midazolam, free and conjugated 1-hydroxymidazolam and 4-hydroxymidazolam in pediatric plasma: Application to Pediatric Pharmacokinetic Study.

  2017influential citation
• An ultra-sensitive LC-MS/MS method to determine midazolam levels in human plasma: development, validation and application to a clinical study.

  2017cites this paper
• Direct Injection LC-MS-MS Analysis of Opiates, Methamphetamine, Buprenorphine, Methadone and Their Metabolites in Oral Fluid from Substitution Therapy Patients.

  2015cites this paper
• Utvikling av en sensitiv LC-MS/MS-metode for å kvantifisere midazolam og metabolitter i plasma fra sykelig overvektige pasienter

  2015cites this paper
• Reduction of hyperbilirubinemia with hypericum extract (St. John's Wort) in a patient with Crigler‐Najjar syndrome type II

  2015cites this paper
• Development and Validation of Reverse Phase HPLC Method for the Determination of Midazolam in Human Plasma

  2014cites this paper
• The Effect of Produce Conditions for Preparation of Potentiometric Carbon Paste Sensor for Determination of Midazolam in Pharmaceutical

  2014cites this paper
• Evaluation of human hepatocytes cultured by three-dimensional spheroid systems for drug metabolism.

  2014cites this paper
• DMD048025 785..790

  2013cites this paper
• Identification of the Active Components in Shenmai Injection that Differentially Affect Cyp3a4-Mediated 1′-Hydroxylation and 4-Hydroxylation of Midazolam

  2013cites this paper
• Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1′-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry

  2012cites this paper
• Where the drug meets the road : actual driving, psychomotor performance and roadside drug screening methods in cannabis and ecstasy users

  2012cites this paper
• Development and validation of a method using supported liquid extraction for the simultaneous determination of midazolam and 1'-hydroxy-midazolam in human plasma by liquid chromatography with tandem mass spectrometry detection.

  2012cites this paper
• [Phenotyping of enzymes participating in drug metabolism].

  2012cites this paper
• Mild hypothermia decreases fentanyl and midazolam steady-state clearance in a rat model of cardiac arrest

  2012cites this paper
• Toxicology testing in alternative specimen matrices.

  2012cites this paper
• High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC-MS/MS.

  2012cites this paper
• Simultaneous Determination of 1,4-Benzodiazepines and Tricyclic Antidepressants in Saliva after Sequential SPE Elution by the Same HPLC Conditions

  2011cites this paper
• Analyses of benzodiazepines and their metabolites in various biological matrices by LC-MS(/MS).

  2011cites this paper
• "In-vivo" phenotyping of CYP3A using midazolam as probe drug : development of novel approaches based on highly sensitive LC-MS/MS methods

  2011cites this paper
• A highly sensitive liquid chromatography tandem mass spectrometry method for simultaneous quantification of midazolam, 1'-hydroxymidazolam and 4-hydroxymidazolam in human plasma.

  2011influential citation
• Rapid and simultaneous measurement of midazolam, 1'-hydroxymidazolam and digoxin by liquid chromatography/tandem mass spectrometry: application to an in vivo study to simultaneously measure P-glycoprotein and cytochrome P450 3A activity.

  2011cites this paper
• Stability study of six 1,4-benzodiazepines in bio-fluids stored at-20°C

  2010cites this paper
• Quantification of midazolam, morphine and metabolites in plasma using 96-well solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry.

  2010cites this paper
• Automated online solid phase extraction ultra high performance liquid chromatography method coupled with tandem mass spectrometry for determination of forty-two therapeutic drugs and drugs of abuse in human urine.

  2010cites this paper
• High performance liquid chromatographic assay for the simultaneous determination of midazolam and ketoconazole in plasma.

  2010cites this paper
• Bioanalysis in drug discovery and development

  2010cites this paper
• Differential effect of Shenmai injection, a herbal preparation, on the cytochrome P450 3A-mediated 1'-hydroxylation and 4-hydroxylation of midazolam.

  2009cites this paper
• HPLC Method for Simultaneous Determination of 1,4-Benzodiazepines and Tricyclic Antidepressants in Pharmaceutical Formulations and Saliva—A Useful Tool in Medicinal Chemistry

  2009cites this paper
• Measurement of xenobiotics in saliva: is saliva an attractive alternative matrix? Case studies and analytical perspectives.

  2009cites this paper
• Current technologies and considerations for drug bioanalysis in oral fluid.

  2009cites this paper
• Oral fluid testing for drugs of abuse.

  2009cites this paper
• Validation of a new HPLC method for determination of midazolam and its metabolites: application to determine its pharmacokinetics in human and measure hepatic CYP3A activity in rabbits.

  2009cites this paper
• LC/MS/MS analysis of capsaicin using multiple transition pairs-some view points to ponder.

  2009cites this paper
• Launch editorial.

  2009cites this paper
• Sensitivity enhancement in tandem liquid chromatographic mass spectrometric assays by summation of two transition ion pairs--perspectives.

  2009cites this paper
• Torcetrapib for animal and human pharmacokinetic studies: applicability of chiral and achiral methodologies.

  2009cites this paper
• Sensitivity enhancement and matrix effect evaluation during summation of multiple transition pairs-case studies of clopidogrel and ramiprilat.

  2009cites this paper
• Prediction of transport, pharmacokinetics, and effect of drugs

  2009cites this paper
• Benzodiazepines: sample preparation and HPLC methods for their determination in biological samples.

  2009cites this paper
• Benzodiazepine metabolism: an analytical perspective.

  2008cites this paper
• Changing need for bioanalysis during drug development.

  2008cites this paper
• Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping.

  2008cites this paper
• Development and validation of a sensitive LC-MS/MS method with electrospray ionization using multiple ions for quantitation of torcetrapib in hamster and dog plasma.

  2008cites this paper
• The role of alternative specimens in toxicological analysis.

  2008cites this paper
• Quantitation of benzodiazepines in whole blood by electron impact-gas chromatography-mass spectrometry.

  2008cites this paper
• Pharmacokinetics of Midazolam and Metabolites in a Patient With Refractory Status Epilepticus Treated With Extraordinary Doses of Midazolam

  2008cites this paper